Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity

被引:27
作者
Hilburger, ME
Adler, MW
Rogers, TJ
Eisenstein, TK
机构
[1] TEMPLE UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, PHILADELPHIA, PA 19140 USA
[2] TEMPLE UNIV, SCH MED, DEPT PHARMACOL, PHILADELPHIA, PA 19140 USA
关键词
immunomodulation; morphine; lymphocyte; macrophage; flow cytometry; opioids;
D O I
10.1016/S0165-5728(97)00142-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously shown that subcutaneous implantation of a 75 mg morphine pellet results in suppression of the ability of murine splenocytes to mount an antibody response to sheep I ed blood cells, due in part to a reduction of macrophage function. The present studies used flow cytometry to examine whether the decrement in macrophage function in the spleens of morphine-treated mice results from a reduction in macrophage numbers. Parallel analysis was carried out on non-elicited peritoneal cells. In the spleen, morphine resulted in a reduction in the relative proportion of macrophages and B-cells, with a concomitant increase in the proportion of T-cells. Alteration in the ratio of CD4(+) to CD8(+) T-cells was not observed. In contrast, in the peritoneal cavity, morphine increased the number of macrophages and reduced the number of B-cell. Naltrexone blocked all of the chan:es in cellular composition. There results support the conclusion that an important mechanism in the immunosuppression seen in the spleens of mice implanted with morphine pellets is a differential reduction in the number of macrophages and B-cells as compared with T-cells. Further, these studies show that subsets of cells of the immune system are differentially affected by morphine in different anatomical compartments. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:106 / 114
页数:9
相关论文
共 45 条
[1]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[2]   MORPHINE-INDUCED IMMUNE ALTERATIONS INVIVO [J].
ARORA, PK ;
FRIDE, E ;
PETITTO, J ;
WAGGIE, K ;
SKOLNICK, P .
CELLULAR IMMUNOLOGY, 1990, 126 (02) :343-353
[3]   F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE [J].
AUSTYN, JM ;
GORDON, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) :805-815
[4]   MORPHINE-INHIBITION OF LYMPHOCYTE ACTIVITY IS MEDIATED BY AN OPIOID DEPENDENT MECHANISM [J].
BAYER, BM ;
DAUSSIN, S ;
HERNANDEZ, M ;
IRVIN, L .
NEUROPHARMACOLOGY, 1990, 29 (04) :369-374
[5]   DISTINCTION BETWEEN THE INVITRO AND INVIVO INHIBITORY EFFECTS OF MORPHINE ON LYMPHOCYTE-PROLIFERATION BASED ON AGONIST SENSITIVITY AND NALTREXONE REVERSIBILITY [J].
BAYER, BM ;
GASTONGUAY, MR ;
HERNANDEZ, MC .
IMMUNOPHARMACOLOGY, 1992, 23 (02) :117-124
[6]  
BRYANT HU, 1988, J PHARMACOL EXP THER, V245, P913
[7]   IMMUNOSUPPRESSIVE EFFECTS OF CHRONIC MORPHINE TREATMENT IN MICE [J].
BRYANT, HU ;
BERNTON, EW ;
HOLADAY, JW .
LIFE SCIENCES, 1987, 41 (14) :1731-1738
[8]   DIFFERENTIAL-EFFECTS OF MORPHINE AND NALTREXONE ON THE ANTIBODY-RESPONSE IN VARIOUS MOUSE STRAINS [J].
BUSSIERE, JL ;
ADLER, MW ;
ROGERS, TJ ;
EISENSTEIN, TK .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1992, 14 (03) :657-673
[9]  
BUSSIERE JL, 1993, J PHARMACOL EXP THER, V264, P591
[10]  
BUSSIERE JL, 1992, LIFE SCI, V52, pPL43